Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence

Launched by HAMAD MEDICAL CORPORATION · Dec 7, 2022

Keywords

ClinConnect Summary

In terms of intervention we are giving six weeks motivational training ( 3 face face session and 2 telephonic follow ups).

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • +18 years old or over,
• • Patients with at least two of the identified comorbidities (Hypertension, Chronic painful condition, Cancer, Inflammatory connective tissue disorders, Diabetes, Lipid disorder, Dyspepsia and gastroenteritis, Heart disease, Chronic obstructive pulmonary disease, Stroke and cerebrovascular disease , chronic kidney disorder , Asthma Thyroid disorders, Anemia, Chronic liver disease, Depression, Epilepsy, Anxiety \& other stress related disorders), (3) having at least one medication prescribed for a chronic condition over at least the 3 months prior to inclusion in the study,
• • Non-adherence to medications, as defined by scoring zero on the 8-item Medication Adherence Report Scale (Morisky -8)(29),
• • Independently managing their medications (i.e., not rely on a care taker),
• • Able to speak or understand English/Arabic,
• • Able and willing to receive phone calls, and
• • Capable of providing a written informed consent to participate in the study.
• Exclusion Criteria:
• • Being institutionalized in a long-term care facility,
• • Planning to move away from the community in the next 6 months,
• • Cognitive impairment (Mini-cog scores \< 4), and
• • Currently participating in research involving chronic disease management. Patients with cognitive impairment are excluded because they may not be able to provide valid answers to the questionnaires.